RxSight Investor Relations Material

RxSight Inc. is a medical technology company focused on developing and commercializing adjustable intraocular lenses (IOLs) for patients undergoing cataract surgery. The company's flagship product, the Light Adjustable Lens (LAL), allows for non-invasive adjustments to the lens after implantation, improving visual outcomes. RxSight's technology provides cataract patients with more precise vision correction by enabling post-surgical adjustments tailored to individual needs. The company is headquartered in Aliso Viejo, California, and its shares are listed on the NASDAQ.